BioMelbourne Network Progressing BioIndustry

2014 Prime Minister's Prizes for Science.
CLOSING DATE: 29 May, 5.00 pm local time in Canberra More

Victorian BioPortal

Looking for Something?

The Victorian BioPortal is the largest online search engine for biotechnology in Victorian with over 2,000 individual listings.

Start your search now

BioMelbourne Network

The Building Global Bridges program provides grants of between $100,000 & $500,000 to Victorian life science companies to develop partnerships with Massachusetts companies in late stage life sciences R&D projects. The program helps Victorian innovation to accelerate, access expertise, develop skills & better reach global markets and international investors. Applications close 17 September 2013.

Building Global Bridges

Victorian Infection and Immunity Network organisations top the Asia-Pacific region

15th April - Victoria has topped recent rankings released by the Nature Publishing Group, with three Victorian Infection and Immunity Network (VIIN) institutions named the top Asia-Pacific contributors to the prestigious Nature Immunology journal. Topping the rankings for 2013, the University of Melbourne, Walter and Eliza Hall Institute of Medical Research and Monash University contributed a ... read more…

Burnet Institute secures medical research and development agreement in China

14th April - Australian medical research and public health organisation, Burnet Institute has signed aAUD$5million agreement with GuoMinXinHe Investment Fund, Beijing to develop low-costdiagnostic tests to improve the health of millions of people in China and around the world. The agreement between the two organisations was officially signed in Shanghai today aspart of the Prime Minister’s Tra... read more…

Global Kinetics Corp Selected to Present at Cavendish Global Health Impact Forum

7th April - ..Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving and philanthropy opportunities within health and life sciences..One of only two Australian companies participating Melbourne, Australia 7 April 2014: Australian Parkinson’s Disease technology company Global Kinetics Corporation (GKC) has been selected to present at ... read more…

2014 Prime Minister's Prizes for Science

21st March - CLOSING DATE: 29 May, 5.00 pm local time in Canberra Online nominations: http://www.industry.gov.au/scienceprizes The Prime Minister's Prizes for Science are Australia’s national annual awards for recognition of outstanding achievement in science and excellence in science education. Nominations are open to Australian citizens and Australian permanent residents.  The five awards a... read more…

Speacialised Therapeutics Australia Receives therapeutic Goods Administration Approval for Abraxane® In Combination with Gemcitabine for First-Line Treatment of Metastatic Pancreatic Cancer

13th March - Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that ABRAXANE® (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in now approved by the Therapeutic Goods Administration (TGA) for the first-line treatment of metastatic pancreatic cancer. The TGA approved indication is: ABRAXANE, in combination with gemcitab... read more…

Victoria extends life sciences collaboration with Massachusetts

12th March - Victorian Coalition Government extends partnership with Massachusetts Life Sciences Center (MLSC) Coalition Government commits $1 million to second round of Building Global Bridges initiative Coalition Government supporting internationalisation of Victorian life sciences industry The Victorian Coalition Government has extended its partnership with renowned innovation invest... read more…

New program to accelerate medtech innovation

12th March - Victorian Coalition Government supporting new medtech program providing free mentoring Victorian medtech companies to benefit from world-leading expertise Coalition Government driving innovation and growth across the state’s life sciences sector Minister for Technology Gordon Rich-Phillips has announced the Victorian Coalition Government is supporting a new program that pr... read more…

Sienna adds talent and capacity in inaugural COO role

4th March - • Appointment of industry leader to emerging company• Growing team to drive and fast-track global activities• Innovative telomerase technology set for roll out in US markets in 2014 Sienna Cancer Diagnostics has appointed Matthew Hoskin as Chief Operating Officer in a move which strengthens the company’s capacity as it progresses commercialisation of its innovative technology for ... read more…

L'Oréal Australia & New Zealand For Women in Science Fellowship applications now open

3rd March - Applications are now open for the 2014 L’Oréal Australia & New Zealand For Women in Science Fellowships We’re offering three AU$25,000 Fellowships for outstanding young female scientists through the highly competitive For Women in Science Fellowship program. The Fellowships will be awarded to three Australian or New Zealand women who have shown scientific excellence in their career... read more…

Phosphagenics Appoints Three New Non-Executive Directors

3rd March - Australian drug delivery technology company Phosphagenics Limited (ASX:POH; OTCQX:PPGNY) has appointed biotech industry veterans Mr Lawrence Gozlan, Mr Nathan Drona and Dr Geert Cauwenbergh as non-executive directors, with Mr Gozlan assuming the role of Chairman of the Board on an interim basis.   Mr Stuart James, Dr Sandra Webb, Mr Don Clarke and Mr Jonathan Addison have retired fr... read more…

Cancer Therapeutics Cooperative Research Centre (CTx) Successful in Application for Further Funding

24th February - Melbourne, Australia, 24th February 2014- Cancer Therapeutics CRC (CTx) is pleased to announce that the Cooperative Research Centres (CRC) Program has agreed to continue their funding for a further six years. The application, submitted in June 2013, highlighted both the success of CTx since its formation in July 2007 as well as the plans to build on that success.  The focus of t... read more…

AXIRON LAUNCHED BY ELI LILLY IN GERMANY

24th February -  Axiron® launched by Eli Lilly in Germany  Testosterone therapy market in Germany is the second largest outside the US Acrux (ASX: ACR) today confirmed that Axiron® has now launched in Germany for testosterone replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism). Germany is the second largest testost... read more…

Watermark Intellectual Property Attorneys and Lawyers expand Attorney practice with Australian Biotech Expert

21st February - Dr Tania Obranovich has joined the Watermark Melbourne office as Special Counsel. Tania practices as both a patent attorney and solicitor, specialising exclusively in biotechnology. She brings to Watermark the experience obtained in pursuing molecular and cellular immunology research to the post-doctoral level, as well as 20 years experience as an attorney with another national... read more…

Driving research and delivering results for Australia

21st February - The Australian Government will create three new Cooperative Research Centres (CRCs) and extend four existing CRCs to drive research that will deliver practical benefits to industry and the community in fields including manufacturing, agriculture, health care and data security. Announcing almost $186 million in funding, Minister for Industry Ian Macfarlane said CRCs bring togeth... read more…

Sienna wins A$800,000 grant for commercialisation of bladder cancer test

20th February - · World first offering of a telomerase-based cancer diagnostic for bladder cancer · Cost-effective non-invasive urine-based test for key biomarker · Bladder cancer the fifth most common cancer in USA, but most expensive to treat Melbourne-based biotech firm Sienna Cancer Diagnostics has been awarded a Federal Government grant to commercialise its innovative technology for us... read more…

The Hamer Scholarships program - Language Study in China, Indonesia, Japan and Korea

6th February - As part of the Victorian International Engagement Strategy the Victorian Government has established the Hamer Scholarships, a language and cultural immersion program designed to build the Asia-engagement capabilities of Victorians and help strengthen cultural awareness between Victoria and Asia. The program provides scholarships for Victorians each year to undertake intensive la... read more…

Spinifex Pharmaceuticals’ Phase 2 Results Published in The Lancet Show EMA401 to be Effective in Reducing Pain in Postherpetic Neuralgia

5th February - • Phase 2 trial met its primary endpoint, reduced pain in postherpetic neuralgia (PHN) versus placebo• Significant patient response to EMA401 treatment and drop in pain intensity compared with placebo, meeting a key secondary endpoint • First published demonstration of the therapeutic potential of angiotensin II type 2 (AT2) receptor antagonists• EMA401 identified as a possible ... read more…

College Group to rebrand as Instinctif Partners

3rd February - Global business communications consultancy, College Group (including leading brands College Hill, The College, College Public Policy, Policy Action, Green Issues Communique, Stockheim Media and Instinctif) announces that it is today rebranding and unifying its business operations under one single brand – Instinctif Partners.  This move sees all its operations – 20 wholly owned of... read more…

IDT Secures Option to Acquire Hormone Replacement Therapy Product Filing from Perrigo Company plc

28th January - • Hormone replacement therapy (HRT) a large and growing therapeutic segment• Opportunity for IDT to acquire a HRT product application in the mid stages of FDA review• Good fit to IDT facilities and capabilities• Attractive commercial terms IDT Australia Limited (ASX:IDT) has secured an exclusive option agreement with Perrigo Company plc (Perrigo) to evaluate an acquisition of P... read more…

Novartis Launches Voveran® TPM Gel in India

21st January, 2014• Novartis has launcheda diclofenac formulation under the product name Voveran®TPM gel in the Indian market• Themis’ launch of its diclofenac product Instanac® TPM gel in the Indian market will occur imminently Drug delivery technology company Phosphagenics Limited (ASX:POH; OTCQX:PPGNY) advises that Novartis has launched a topical diclofenac gel that has been formulated with... read more…